Alfred Kim, MD
Rheumatology · Saint Louis, MONPI 1124105234
Payments from drug & device makers
Across 788 payments — averaging $1500.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$513K
- Astrazeneca UK Limited$402K
- Novartis$92K
- Bristol Myers Squibb$56K
- Pfizer$21K
- AbbVie$21K
- plus $78K from 21 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 335 | $512,688 |
| Astrazeneca UK Limited | 6 | $401,637 |
| Novartis | 94 | $92,053 |
| Bristol Myers Squibb | 2 | $55,952 |
| Pfizer | 29 | $21,028 |
| AbbVie | 40 | $20,651 |
| E.r. Squibb & Sons, L.L.C. | 27 | $17,973 |
| AstraZeneca(2 entities) | 57 | $13,934 |
| Aurinia Pharma U.S., Inc. | 33 | $11,798 |
| EMD Serono, Inc. | 4 | $7,213 |
| Janssen Scientific Affairs, LLC | 87 | $6,523 |
| Invivyd Inc | 6 | $4,999 |
| Amgen(2 entities) | 10 | $3,080 |
| Johnson & Johnson(2 entities) | 6 | $2,632 |
| Biogen | 2 | $2,582 |
| ANI Pharmaceuticals, Inc. | 1 | $2,118 |
| Genentech USA, Inc. | 1 | $1,915 |
| Sanofi | 10 | $968 |
| Genentech, Inc. | 16 | $592 |
| Mallinckrodt Hospital Products Inc. | 7 | $589 |
| UCB, Inc. | 4 | $320 |
| Lilly USA, LLC | 3 | $252 |
| Mallinckrodt Enterprises LLC | 4 | $156 |
| Apellis Pharmaceuticals, Inc. | 1 | $139 |
| Calliditas Therapeutics US Inc. | 1 | $128 |
| Sobi, Inc | 1 | $117 |
| Actelion Pharmaceuticals US, Inc. | 1 | $22 |
How this compares
$1,182,057 in reported general payments places this provider in the 95th percentile of 134 rheumatology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Saint Louis
- Sona KamatSaint Louis$931K
- Akgun InceSaint Louis$849K
- Adam KilianSaint Louis$593K
- John BuddSaint Louis$404K
- Chad RonholmSaint Louis$327K
- Reema SyedSaint Louis$313K
- Richard BrasingtonSaint Louis$110K
- Barbara CacioloSaint Louis$98K
- Deborah ParksSaint Louis$91K
- Joseph StauberSaint Louis$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.